Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
PDOs contributes to screening sensitive drugs for HCC patients to realize the personalized treatment and improve the conversion therapy efficacy.
Authors
- Jing Li (ORCID: https://orcid.org/0009-0007-1333-7752)
- Xi Wang (ORCID: https://orcid.org/0009-0002-4464-7183)
- Yonggang He (ORCID: https://orcid.org/0000-0002-3856-4077)
- Xiaobing Huang (ORCID: https://orcid.org/0009-0001-2083-7663)
- Chong-Yu Zhao
- Lu Zheng
- Zheng Wang (ORCID: https://orcid.org/0000-0001-9255-2977)
Institutions
- Army Medical University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.4251/wjgo.v16.i11.4506
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.11